Cargando…
HYCO-3, a dual CO-releaser/Nrf2 activator, reduces tissue inflammation in mice challenged with lipopolysaccharide
Oxidative stress and inflammation are predominant features of several chronic diseases. The nuclear factor erythroid 2-related factor 2 (Nrf2) is a major arbiter in counteracting these insults via up-regulation of several defensive proteins, including heme oxygenase-1 (HO-1). HO-1-derived carbon mon...
Autores principales: | Motterlini, Roberto, Nikam, Aniket, Manin, Sylvie, Ollivier, Anthony, Wilson, Jayne Louise, Djouadi, Sabrina, Muchova, Lucie, Martens, Thierry, Rivard, Michael, Foresti, Roberta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223233/ https://www.ncbi.nlm.nih.gov/pubmed/30391826 http://dx.doi.org/10.1016/j.redox.2018.10.020 |
Ejemplares similares
-
Therapeutic effects of CO-releaser/Nrf2 activator hybrids (HYCOs) in the treatment of skin wound, psoriasis and multiple sclerosis
por: El Ali, Zeina, et al.
Publicado: (2020) -
Increased Sirt1 secreted from visceral white adipose tissue is associated with improved glucose tolerance in obese Nrf2-deficient mice
por: Braud, Laura, et al.
Publicado: (2020) -
Anti-inflammatory activities of carbon monoxide-releasing molecules (CO-RMs) in the brain
por: Motterlini, Roberto, et al.
Publicado: (2015) -
Hybrid Core-Shell (HyCoS) Nanoparticles produced by Complex Coacervation for Multimodal Applications
por: Vecchione, D., et al.
Publicado: (2017) -
Emerging concepts on the anti-inflammatory actions of carbon monoxide-releasing molecules (CO-RMs)
por: Motterlini, Roberto, et al.
Publicado: (2012)